Latest news
How education exposes the moral and ethical limits of our health decision-making - pharmadispatch.compharmadispatch.com · Mon, 10 Aug 2026 15:03:54 GMTThe risk to patients is that new pricing policies could swamp any benefit from the HTA Review - pharmadispatch.compharmadispatch.com · Mon, 03 Aug 2026 18:05:21 GMTThe HTA Review and the 'Abilene paradox' - when everyone argues for reforms that nobody wants - pharmadispatch.compharmadispatch.com · Sun, 02 Aug 2026 15:04:31 GMTAI will likely grow the HTA 'industrial complex', but it can also democratise the institution - pharmadispatch.compharmadispatch.com · Wed, 29 Jul 2026 16:02:43 GMT